Ophthalmology

Top Story

Adverum reports significant progress with intravitreal gene therapy program

January 17, 2020

Phase 3 trial to investigate Port Delivery System in DME

January 17, 2020
Genentech and Roche initiated a phase 3 clinical trial to investigate the Port Delivery System with ranibizumab to treat patients with diabetic macular edema, according…
Meeting NewsVideo

VIDEO: Presbyopic IOL challenge

January 17, 2020
NEW YORK — During a presentation at OSN New York 2019, William F. Wiley, MD, reviews his use of the Kamra inlay (CorneaGen) to address a difficult presbyopia…

Kala completes enrollment in STRIDE 3 trial

January 17, 2020
Kala Pharmaceuticals has completed enrollment in the STRIDE 3 trial for KPI-121 0.25%, a treatment for temporary dry eye relief, according to a press release. The…

Q&A: Vision training to improve athletic performance

January 16, 2020
Athletes are continually looking for ways to improve their performance and gain an advantage in training to give them a leg up on their competition. Professional and…
More Headlines »
Clinical Science

Ultra-Widefield Fluorescein Angiography as a Biomarker for Response to Switch in Therapy in Persistent DME

Ophthalmic Surgery, Lasers and Imaging Retina, December 2019, Volume 50 Issue 12
To explore the effect of peripheral ischemia identified on ultra-widefield fluorescein angiography (UWFA) as a…
More »
CME

Diabetic Eye Disease Consults: Volume 3, Issue 2

This activity is supported by independent medical education grants from Genentech, Inc. and Regeneron Pharmaceuticals, Inc.

More »
Resource Centers
OSN New York Meeting

OSN New York Meeting

Video
Meeting News

VIDEO: Presbyopic IOL challenge

January 17, 2020
More »